Impact of intradialytic fiber clotting on dialyzer extraction and solute removal: a randomized cross-over study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 04 2022
Historique:
received: 30 11 2021
accepted: 23 03 2022
entrez: 6 4 2022
pubmed: 7 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

Previous studies revealed the importance of biocompatibility, anticoagulation strategy, and dialysis mode and duration on fiber blocking at the end of a hemodialysis session. The present study was set up in ten hemodialysis patients to relate fiber patency to dialyzer extraction and removal of small and middle molecules. With only 1/4th of the regular anticoagulation dose, and using a Solacea 19H and FX800 CorDiax dialyzer, fiber patency was quantified using 3D micro-CT scanning for different dialysis durations (i.e. 60, 120 and 240 min). While Solacea showed enhanced fiber patency in all test sessions, fiber blocking in the FX800 CorDiax did not follow a linear process during dialysis, but was rather accelerated near the end of dialysis. Dialyzer extraction ratios were correlated with the percentages of open fibers. While the fiber blocking process affected extraction ratios (i.e. for phosphorus and myoglobin in the FX800 CorDiax), it had only minor impact on the removal of toxins up to at least 12 kDa.

Identifiants

pubmed: 35383253
doi: 10.1038/s41598-022-09696-7
pii: 10.1038/s41598-022-09696-7
pmc: PMC8983686
doi:

Substances chimiques

Toxins, Biological 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5717

Informations de copyright

© 2022. The Author(s).

Références

Semin Dial. 2021 Mar;34(2):103-115
pubmed: 33135208
J Am Soc Nephrol. 2021 Jun 17;:
pubmed: 34140394
Clin J Am Soc Nephrol. 2011 Dec;6(12):2854-60
pubmed: 22034502
Kidney Int. 2002 Feb;61(2):655-67
pubmed: 11849409
Int J Artif Organs. 2002 May;25(5):411-20
pubmed: 12074339
Nephrol Dial Transplant. 2009 Jul;24(7):2218-24
pubmed: 19211646
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S62-71
pubmed: 11792764
Clin Kidney J. 2020 Dec 08;14(7):1752-1759
pubmed: 34548919
Sci Rep. 2018 Feb 8;8(1):2677
pubmed: 29422614
Nephrology (Carlton). 2010 Jun;15(4):386-92
pubmed: 20609088
Hemodial Int. 2020 Jan;24(1):61-70
pubmed: 31633275
Contrib Nephrol. 2017;189:215-221
pubmed: 27951571
Kidney360. 2020 Oct 20;1(12):1426-1431
pubmed: 35372898
Clin Kidney J. 2020 Nov 28;14(8):1901-1907
pubmed: 34345413
Hemodial Int. 2018 Oct;22(4):463-473
pubmed: 29745004
Clin Kidney J. 2019 Dec 22;14(1):398-407
pubmed: 33564444
Semin Dial. 2005 Sep-Oct;18(5):401-8
pubmed: 16191181
Kidney Int. 2006 Apr;69(8):1431-7
pubmed: 16395268

Auteurs

Floris Vanommeslaeghe (F)

Nephrology Department, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Gent, Belgium.

Iván Josipovic (I)

Centre for X-Ray Tomography, Physics and Astronomy, Ghent University, Ghent, Belgium.

Matthieu Boone (M)

Centre for X-Ray Tomography, Physics and Astronomy, Ghent University, Ghent, Belgium.

Wim Van Biesen (W)

Nephrology Department, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Gent, Belgium.

Sunny Eloot (S)

Nephrology Department, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Gent, Belgium. sunny.eloot@ugent.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH